Skip to main content
. 2021 May 19;9:656849. doi: 10.3389/fcell.2021.656849

FIGURE 4.

FIGURE 4

Schema showing application of clustered regularly interspaced short palindromic repeats (CRISPR)–dCas13 for N6-methyladenosine (m6A) editing. The m6A editing system is made by fusing deactivated Cas13b (dCas13b) with a guide RNA (gRNA) that can specifically target abnormally methylated messenger RNA (mRNA) (pathogenic mRNA) and coupling of CRISPR–dCas13 to an m6A factor to effect desired changes in m6A modification. Depending on the effector used, it is possible to induce m6A deposition, removal, or recognition (binding/reading), leading to the induction of degradation, translation enhancement, or increased stability of the target mRNA.